CSI FOCUS D-HF: Neuromodulation in the management of heart failure and its comorbidities: diabetes, sleep apnea and hypertension
Friday, 5 February 2021
Moderators:
Howard Levin, Coridea, New York, USA
Felix Mahfoud, Saarland University Hospital, Homburg, Germany
Q&A moderator:
Marat Fudim, Duke University and the Duke Clinical Research Institute, Durham, USA
Shakeel Qureshi, Evelina Children's Hospital, London, United Kingdom
Panelists:
Michael Böhm, Saarland University Hospital, Homburg, Germany
Marshall Heradien, Stellenbosch University, Cape Town, South Africa
William Abraham, Ohio State University, Columbus, USA
Jörn Schmitt, University of Gießen, Gießen, Germany
Horst Sievert, CardioVascular Center Frankfurt CVC, Frankfurt, Germany
Daniel Burkhoff, Cardiovascular Research Foundation, New York, USA
Joachim Ehrlich, St. Josefs-Hospital, Wiesbaden, Germany
PROGRAM
The top heart failure target for renal denervation...
- … should be HFpEF >> Michael Böhm
- … should be HFrEF >> Marat Fudim
- … should be arrhythmias >> Marshall Heradien
Phrenic nerve stimulation with the Remede system >> William Abraham
BAROSTIM to treat HFrEF – Approved therapy for an unmet need! >> Jörn Schmitt
Endovascular ablation of the right greater splanchnic nerve >> Horst Sievert
Backbeat >> Daniel Burkhoff
Cardiac contractility modulation - How it works >> Joachim Ehrlich
An endovascular approach to Baroreflex neuromodulation >> Horst Sievert
The webinar was accredited by the European Board for Accreditation in Cardiology (EBAC) with 2 CME credits.
This webinar was supported by:
